Krallinger, CM; Saadi, H; Mayrhofer, K; Krauter, J; Kiesl, D; Vais, D; Schnabel, S; Gampenrieder, SP; Miechowiecki, J; Wiesinger, CG; Banner, A; Stoiber, F; Spiegelberg, JA; Mühlmann, J; Vallet, S; Andalibi, H; Aufderklamm, S; Weibrecht, S; Hilbe, W; Shariat, S; Pfuner, J; Heintel, D; Pichler, R; Niedersüss-Beke, D.
FGFR3 Testing Frequency and Outcomes in Patients Treated with Enfortumab-Vedotin for Metastatic Urothelial Carcinoma and FGFR3-Alteration: An Austrian Multicentre Study
ONCOL RES TREAT. 2025; 48(SUPPL 2):
Web of Science